Green Thumb Industries (GTBIF) Amortization of Deferred Charges (2019 - 2026)
Green Thumb Industries (GTBIF) posted Amortization of Deferred Charges of $13.4 million for Q1 2026, up 8305.0% on a QoQ basis from $160000.0 in Q4 2025, and up 5.33% year-over-year from $12.8 million in Q1 2025.
Green Thumb Industries (GTBIF) Amortization of Deferred Charges (2019 - 2026) Analysis & Trends
Green Thumb Industries' Amortization of Deferred Charges history runs 8 years deep, the most recent figure standing at $13.4 million for Q1 2026.
- Quarterly Amortization of Deferred Charges rose 5.33% year-over-year to $13.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.3 million (down 90.4% YoY) and the FY2025 annual result came in at $639000.0, down 79.21% from the prior year.
- Amortization of Deferred Charges was $13.4 million for Q1 2026 at Green Thumb Industries, up from $160000.0 in the prior quarter.
- Across five years, Amortization of Deferred Charges topped out at $31.2 million in Q3 2023 and bottomed at -$25.1 million in Q3 2025.
- A 5-year average of $4.4 million and a median of $2.4 million in 2023 frame the typical range for Amortization of Deferred Charges.
- Peak annual rise in Amortization of Deferred Charges reached 1148.72% in 2022, while the deepest fall reached 177.93% in 2022.
- Green Thumb Industries' Amortization of Deferred Charges stood at -$22.7 million in 2022, then surged by 153.82% to $12.2 million in 2023, then plunged by 98.69% to $160000.0 in 2024, then changed by 0.0% to $160000.0 in 2025, then soared by 8305.0% to $13.4 million in 2026.
- Business Quant data shows GTBIF's Amortization of Deferred Charges at $13.4 million in Q1 2026, $160000.0 in Q4 2025, and -$25.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 90.13 Bn | 88.27 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.98 Bn | 32.24 Bn | 1.97 Bn |
| 3 | Zoetis | 32.59 Bn | 30.65 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.55 Bn | 23.49 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.08 Bn | 20.93 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - |
| 7 | Viatris | 20.38 Bn | 18.57 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.80 Bn | 16.48 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.64 Bn | 12.21 Bn | 785.00 Mn |
| 10 | Green Thumb Industries | 1.65 Bn | 1.30 Bn | 143.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.45 Mn |
| Mar 31, 2026 | 13.45 Mn |
| Dec 31, 2025 | 160,000.00 |
| Dec 31, 2025 | 160,000.00 |
| Sep 30, 2025 | -25.09 Mn |
| Sep 30, 2025 | -25.09 Mn |
| Jun 30, 2025 | 12.80 Mn |
| Jun 30, 2025 | 12.80 Mn |
| Mar 31, 2025 | 12.77 Mn |
| Mar 31, 2025 | 12.77 Mn |
| Dec 31, 2024 | 160,000.00 |
| Dec 31, 2024 | 160,000.00 |
| Sep 30, 2024 | -21.76 Mn |
| Sep 30, 2024 | -21.76 Mn |
| Jun 30, 2024 | 22.58 Mn |
| Jun 30, 2024 | 22.58 Mn |
| Mar 31, 2024 | 2.10 Mn |
| Mar 31, 2024 | 2.10 Mn |
| Dec 31, 2023 | 12.24 Mn |
| Dec 31, 2023 | 12.24 Mn |